These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25183789)

  • 1. Therapies with diverse mechanisms of action kill cells by a similar exponential process in advanced cancers.
    Blagoev KB; Wilkerson J; Stein WD; Yang J; Bates SE; Fojo T
    Cancer Res; 2014 Sep; 74(17):4653-62. PubMed ID: 25183789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cell killing via ROS: to increase or decrease, that is the question.
    Wang J; Yi J
    Cancer Biol Ther; 2008 Dec; 7(12):1875-84. PubMed ID: 18981733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicity.
    Costa MI; Boldrini JL; Bassanezi RC
    Math Biosci; 1995 Feb; 125(2):211-28. PubMed ID: 7881195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell death and cancer therapy.
    Bunz F
    Curr Opin Pharmacol; 2001 Aug; 1(4):337-41. PubMed ID: 11710730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal control of tumor size used to maximize survival time when cells are resistant to chemotherapy.
    Martin RB; Fisher ME; Minchin RF; Teo KL
    Math Biosci; 1992 Jul; 110(2):201-19. PubMed ID: 1498450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy.
    Alagkiozidis I; Facciabene A; Tsiatas M; Carpenito C; Benencia F; Adams S; Jonak Z; June CH; Powell DJ; Coukos G
    J Transl Med; 2011 May; 9():77. PubMed ID: 21609494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic agents triggering nonapoptotic cancer cell death.
    Kornienko A; Mathieu V; Rastogi SK; Lefranc F; Kiss R
    J Med Chem; 2013 Jun; 56(12):4823-39. PubMed ID: 23517069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fighting Resilient Cancers with Iron.
    Chen JJ; Galluzzi L
    Trends Cell Biol; 2018 Feb; 28(2):77-78. PubMed ID: 29223642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular mechanism of cell death induced by chemotherapeutic agents].
    Saya H
    Brain Nerve; 2009 Jul; 61(7):843-7. PubMed ID: 19618862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of biguanides to improve response to chemotherapy.
    Sandulache VC; Yang L; Skinner HD
    Methods Mol Biol; 2014; 1165():3-9. PubMed ID: 24839014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs.
    Murray M; Hraiki A; Bebawy M; Pazderka C; Rawling T
    Pharmacol Ther; 2015 Jun; 150():109-28. PubMed ID: 25603423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapeutic targeting of cell death pathways.
    Mansilla S; Llovera L; Portugal J
    Anticancer Agents Med Chem; 2012 Mar; 12(3):226-38. PubMed ID: 22263795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of cell death signaling in cancer: impact on disease prognosis and response to therapy.
    Güner D; Belka C; Daniel PT
    Curr Med Chem Anticancer Agents; 2003 Sep; 3(5):319-26. PubMed ID: 12871077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the weak point of cancer by induction of necroptosis.
    Hu X; Han W; Li L
    Autophagy; 2007; 3(5):490-2. PubMed ID: 17617736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. For cancer, seek and destroy or live and let live?
    André N; Pasquier E
    Nature; 2009 Jul; 460(7253):324. PubMed ID: 19606124
    [No Abstract]   [Full Text] [Related]  

  • 17. Is Gompertzian or exponential kinetics a valid description of individual human cancer growth?
    Retsky MW; Swartzendruber DE; Wardwell RH; Bame PD
    Med Hypotheses; 1990 Oct; 33(2):95-106. PubMed ID: 2259298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
    Gao W; Xiang B; Meng TT; Liu F; Qi XR
    Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The types of cell death].
    Stepień A; Izdebska M; Grzanka A
    Postepy Hig Med Dosw (Online); 2007 Jul; 61():420-8. PubMed ID: 17679912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.